Active Ingredient History

  • Now
LIBRAX® combines in a single capsule formulation the antianxiety action of chlordiazepoxide hydrochloride and the anticholinergic/spasmolytic effects of clidinium bromide. Chlordiazepoxide hydrochloride is a versatile, therapeutic agent of proven value for the relief of anxiety and tension. It is indicated when anxiety, tension or apprehension are significant components of the clinical profile. It is among the safer of the effective psychopharmacologic compounds. Clidinium bromide is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. It inhibits muscarinic actions of acetylcholine at postganglionic parasympathetic neuroeffector sites. LIBRAX® is indicated to control emotional and somatic factors in gastrointestinal disorders. It may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.   NCATS

More Chemistry

Combination drugs

3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-methyl-1-azonia-bicyclo[2.2.2]octane | 3-hydroxy-1-methylquinuclidinium benzilate ester | bromure de clidinium | bromuro de clidinio | clidinii bromidum | clidinium | clidinium, 11c-labeled | clidinium, 1-(methyl-11c)-labeled | clidinium, 3h-labeled | clidinium bromid | clidinium bromide | clidinium iodide | clidinium iodide, 11c-labeled | clidinium iodide, 3h-labeled | clidinium iodide, (+-)-isomer | n-methyl quinuclidinyl benzilate | quarzan | ro-23773


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue